Consolidated Statements Of Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Sales	$ 390,381	$ 43,466
Operating expenses
General and administrative	4,528,437	892,549
Research and development	361,200
Total expenses	4,889,637	892,549
Loss from operations	(4,499,256)	(849,083)
Other income (expense)
Amortization of debt discount and interest expense	108,752	28,784
Loss on settlement of debt	(3,488,400)
Total other income (expense)	(3,597,152)	(28,784)
Net loss	$ (8,096,408)	$ (877,867)
Net loss per common share - basic and diluted	$ (0.18)	$ (1.08)
Weighted average number of common shares outstanding - basic and diluted	45,694,692	812,435